Intelligence Profile
Research Papers
Research Papers and Clinical Trials
Current research on exosome scalp microneedling for hair loss is emerging but limited. Three published studies provide initial evidence:
Published Clinical Research:
A 2025 study in the Journal of Drugs in Dermatology (PMID: 41037530) examined an exosome regenerative complex combined with microneedling in subjects with self-perceived thinning hair, reporting hair growth promotion. However, specific study design details and sample sizes are not available from the provided evidence.
Another 2025 prospective study published in Aesthetic Plastic Surgery (PMID: 40146273) focused specifically on exosome therapy for androgenetic alopecia, though again detailed methodology and participant numbers are not specified in the available information.
A 2026 study in Life (PMID: 42073416) investigated platelet-rich plasma regimens for non-scarring alopecia, examining baseline neutrophil-to-lymphocyte ratios as predictive markers. While not directly focused on exosomes, this research provides context for regenerative scalp treatments.
Ongoing Clinical Trials:
Four registered clinical trials are currently investigating exosome-based treatments for hair thinning:
- One completed study (NCT06571799) evaluated BENEV Exosome Regenerative Complex for self-perceived thinning hair
- Two active trials are examining exosome delivery via microneedling in women with hair thinning (NCT07221773) and TargetCool plus BENEV exosomes (NCT06999408)
- One recruiting trial (NCT07373054) is studying umbilical cord mesenchymal stem cell-derived exosomes for androgenic alopecia
Evidence Limitations:
The available evidence is preliminary, with limited published data on sample sizes, study methodologies, and detailed outcomes. Most research appears to be in early phases, and comprehensive peer-reviewed results are not yet available for many ongoing trials.
This information is for educational purposes only and should not replace consultation with a qualified healthcare provider for personalized medical advice.